Safety of Valganciclovir 450 mg 3 Times Weekly for Cytomegalovirus Prophylaxis in Solid Organ Transplant Recipients Requiring Hemodialysis.

Ecabert, Danielle; Pham, Christine; Pierce, Brett J; Musick, William L; Nguyen, Duc T; Graviss, Edward A

Ecabert, Danielle; Pham, Christine; Pierce, Brett J; Musick, William L; Nguyen, Duc T; Graviss, Edward A.

Afiliação

Ecabert D; Houston Methodist Hospital, Department of Pharmacy, Houston, Texas,USA.
Pham C; Houston Methodist Hospital, Department of Pharmacy, Houston, Texas,USA.
Pierce BJ; Houston Methodist Hospital, Department of Pharmacy, Houston, Texas,USA.
Musick WL; Houston Methodist Hospital, Department of Pharmacy, Houston, Texas,USA.
Nguyen DT; Houston Methodist Hospital, Department of Pathology and Genomic Medicine, Houston, Texas,USA.
Graviss EA; Houston Methodist Hospital, Department of Pathology and Genomic Medicine, Houston, Texas,USA.

Open Forum Infect Dis ; 8(10): ofab436, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34646907

Palavras-chave

cytomegalovirus; hemodialysis; prophylaxis; solid organ transplant; valganciclovir

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google